Snapshots of studies of CXA-101 alone and in combination with tazobactam presented at ICAAC: II Sep. 25, 2009
PF-04287881 shows potent in vitro and in vivo antibacterial activity in respiratory tract infections Sep. 23, 2009
Synthetic pleuromutilin derivatives evaluated by Nabriva for the treatment of bacterial infections Sep. 23, 2009
Fully human anti-DKK1 monoclonal antibody increases bone formation in osteopenia models Sep. 23, 2009
DAS-181 shows potent preclinical activity against H1N1, H5N1 and seasonal influenza virus Sep. 22, 2009
RSS